Dermata Therapeutics Inc

NASDAQ:DRMA   3:59:50 PM EDT
4.34
-0.18 (-3.98%)
Earnings Announcements

Dermata Therapeutics Says As Of June 30, Co Had $427,202 In Cash

Published: 09/27/2021 21:29 GMT
Dermata Therapeutics Inc (DRMA) - Dermata Therapeutics - As of June 30, 2021, Co Had $427,202 in Cash.
Dermata Therapeutics Inc Qtrly Net Loss per Common Share, Basic and Diluted $0.70.
Further Company Coverage: Drmao ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.